Arch Biopartners Inc.

TSXV:ARCH Stock Report

Market Cap: CA$124.8m

Arch Biopartners Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

TSXV:ARCH Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Feb 25SellCA$9,450Richard MuruveIndividual5,000CA$1.89
16 Jan 25BuyCA$2,286Richard MuruveIndividual1,200CA$1.93
31 Dec 24BuyCA$6,974Richard MuruveIndividual3,700CA$1.90
24 Dec 24BuyCA$3,786Richard MuruveIndividual2,100CA$1.81
20 Dec 24BuyCA$10,939Richard MuruveIndividual6,300CA$1.77
29 Nov 24SellCA$3,920Richard MuruveIndividual2,000CA$1.96
25 Nov 24BuyCA$960Richard MuruveIndividual500CA$1.95
24 Oct 24SellCA$10,300Richard MuruveIndividual5,000CA$2.06
04 Oct 24SellCA$1,850Richard MuruveIndividual1,000CA$1.85
27 Sep 24SellCA$10,550Richard MuruveIndividual6,000CA$1.78
18 Sep 24SellCA$4,860Richard MuruveIndividual3,000CA$1.62
10 Sep 24SellCA$1,350Richard MuruveIndividual900CA$1.50
06 Sep 24SellCA$900Richard MuruveIndividual600CA$1.50
21 Jun 24SellCA$172,000Andrew BishopIndividual100,000CA$1.72
06 Jun 24BuyCA$1,661Richard MuruveIndividual1,000CA$1.66
31 May 24BuyCA$3,666Richard MuruveIndividual2,200CA$1.68
22 May 24BuyCA$149,999Richard MuruveIndividual85,714CA$1.75
21 May 24SellCA$149,999Daniel MuruveIndividual85,714CA$1.75
08 Mar 24SellCA$3,632Richard MuruveIndividual2,104CA$1.73

Insider Trading Volume

Insider Buying: ARCH insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ARCH?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders14,880,92922.9%
General Public50,060,02777.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 5 shareholders own 22.91% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15%
Richard Muruve
9,706,310CA$18.6m-0.04%no data
3.3%
Richard Rossman
2,140,000CA$4.1m0%no data
3.15%
Daniel Muruve
2,047,619CA$3.9m0%no data
1.2%
Andrew Bishop
780,000CA$1.5m0%no data
0.32%
Claude Allary
207,000CA$397.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/22 13:24
End of Day Share Price 2025/02/21 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Arch Biopartners Inc. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Chelsea StellickiA Capital Markets
Rahul SarugaserRaymond James Ltd.